RecruitingNot Applicable

Seminar in Unwavering Empowering Presence Optimized for Rehabilitation Teams

United States25 participantsStarted 2025-07-09

Plain-language summary

The goal of this study to test the feasibility, acceptability, and potential impact of a serious illness communication skills training (CST) tailored to rehabilitation professionals to improve their comfort and confidence in navigating difficult conversations with patients and families. Primary Objectives: Aim 1: To assess feasibility and acceptability of a multidisciplinary co-designed interactive CST program for rehabilitation professionals who care for children with serious illness and their families. Aim 2: To characterize the potential impact of this CST intervention on pediatric rehabilitation professionals. Secondary Objective: Aim 3: To examine the perspectives of bereaved parent educators on participation in the implementation of communication training for rehabilitation professionals.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Intervention Participants * Licensed rehabilitation professionals (e.g., physical therapists, occupational therapists, speech-language pathologists) employed at St. Jude Children's Research Hospital actively involved in the care of pediatric oncology patients. * Willingness to participate in the communication skills training (CST) intervention and associated study activities. Inclusion Criteria: Intervention Facilitators * St. Jude Bereaved Parent Educators who have participated as an educator in at least one other institutional educational event * Willingness to facilitate the communication skills training (CST) intervention and complete associated study activities. Exclusion Criteria: Intervention Participants * Non-rehabilitation professionals * Individuals unable to attend the CST intervention session. Exclusion Criteria: Intervention Facilitators * Individuals unable to attend the CST intervention session.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Proportion of participants who achieve a mean score ≥3 on the Feasibility of Intervention Measure (FIM) scale

Timeframe: Approximately 3 months post intervention

Proportion of participants who achieve a mean score ≥3 on Acceptability of Intervention Measure (AIM) scale

Timeframe: Approximately 3 months post intervention

Proportion of participants who achieve a mean score ≥3 on the Intervention Appropriateness Measure (IAM) scale

Timeframe: Approximately 3 months post intervention

Potential impact of this CST intervention on pediatric rehabilitation professionals

Timeframe: Prior to the start of the intervention (day 1) and at the end of study, approximately 3 months

Trial details

NCT IDNCT07071116

SponsorSt. Jude Children's Research Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07

Contact for this trial

Brittany Cowfer, MD

888-226-4343 referralinfo@stjude.org

View on ClinicalTrials.gov More Communication trials

Plain-language summary

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Proportion of participants who achieve a mean score ≥3 on the Feasibility of Intervention Measure (FIM) scale

Timeframe: Approximately 3 months post intervention

Proportion of participants who achieve a mean score ≥3 on Acceptability of Intervention Measure (AIM) scale

Timeframe: Approximately 3 months post intervention

Proportion of participants who achieve a mean score ≥3 on the Intervention Appropriateness Measure (IAM) scale

Timeframe: Approximately 3 months post intervention

Potential impact of this CST intervention on pediatric rehabilitation professionals

Timeframe: Prior to the start of the intervention (day 1) and at the end of study, approximately 3 months